Russia New Corona Vaccine Starts Final Phase Clinical Trials September 10 6:47
Russia has announced that it has started the final stage of clinical trials for the development of a new coronavirus vaccine, and since November this year it will carry out mass vaccinations for healthcare workers and others.
In Russia, the National Institute of Epidemiology and Microbiology of Gamalya is advancing vaccine development for the new coronavirus, and the Russian Ministry of Health announced on the 9th that the final clinical trial of three stages has started at a medical institution in Moscow. Did.
The clinical trial will be conducted in 40,000 people who want to be followed up for half a year.
The vaccine is named "Sputnik V" after the name of the first satellite launched by the former Soviet Union in 1957, and the Russian government approved it at the end of last month when only the second stage clinical trial was completed. did.
Some Russian officials involved in the development show that they succeeded in the development ahead of the U.S., and question the safety and effectiveness of Russia's vaccine development at home and abroad as political. There is a point of view.
Meanwhile, a Russian research group reported this month in the British medical journal Lancet that early clinical trials did not show any serious health effects, the Russian government said. After November, it is planned to carry out group vaccinations for medical professionals.